Increased serum triglyceride clearance, unchanged cholesteryl ester transfer protein activity, and elevated HDL cholesterol during treatment of hypertriglyceridemia with bezafibrate
References (26)
The triglyceride issue: A view from Framingham
Am Heart J.
(1986)High density lipoprotein metabolism
J Lipid Res
(1984)- et al.
Effect of BM 15.075 on lipoprotein concentrations in different types of hyperlipoproteinaemia
Atherosclerosis
(1977) - et al.
Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia
Atherosclerosis
(1978) - et al.
Isolation, characterization, and assay of plasma lipid transfer proteins
- et al.
Elevated lipoprotein lipase activity in skeletal muscle tissue during treatment of hypertriglyceridaemic patients with bezafibrate
Atherosclerosis
(1982) - et al.
Double-blind comparison of bezafibrate versus placebo in male volunteers with hyperlipoproteinemia
Atherosclerosis
(1992) - et al.
Intravenous fat tolerance: Correlation with very low density lipoprotein apoprotein B kinetics in man
Atherosclerosis
(1977) - et al.
Plasma high-density lipoprotein concentration and subfraction distribution in relation to triglyceride metabolism
Am Heart J
(1987) - et al.
Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjects
Atherosclerosis
(1982)
High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease
Br Heart J
(1988)
Coronary risk factors in angiographically defined patients with chest pain
Jpn J Med
(1990)
A simplified intravenous fat emulsion tolerance test
J Clin Biochem Nutr
(1987)
Cited by (7)
Increased Serum Triglyceride Clearance and Elevated High-Density Lipoprotein 2 and 3 Cholesterol during Treatment of Primary Hypertriglyceridemia with Bezafibrate
2003, Current Therapeutic Research - Clinical and ExperimentalImprovement in hyperchylomicronemia, transient deficiency in lipoprotein lipase and hepatic triglyceride lipase activity, and diabetes mellitus produced by pravastatin and bezafibrate: a case report
1996, Current Therapeutic Research - Clinical and ExperimentalKinetics of an intravenously injected fat emulsion reflect postheparin plasma lipoprotein lipase mass and activity
2002, Journal of Clinical Biochemistry and NutritionSignificant correlation between fractional removal rate (K<inf>2</inf>) of fat emulsion and serum triglyceride or apolipoprotein A-I in subjects with ApoE phenotype 3/3
1997, Journal of Clinical Biochemistry and Nutrition
Copyright © 1994 Published by Elsevier Inc.